Evidence map›Paper›PMID 36530683›Full record

ArticleFrontiers in public health2022

An analysis of the etiologies and economic indexes of inpatients with stage 5 chronic kidney disease in North China.

Shan-Shan Guo, Yan-Li Gou, Jian-Dong Li, Hong-Fang Zhang, Yang Huang, Xi-Jie Zheng, Hang Chen, Zhun Sui

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Shan-Shan GuoDepartment of Nephrology, Affiliated Hospital of Hebei University, Baoding, China.
Yan-Li GouDepartment of Nephrology, Affiliated Hospital of Hebei University, Baoding, China.
Jian-Dong LiDepartment of Nephrology, Affiliated Hospital of Hebei University, Baoding, China.
Hong-Fang ZhangTianjin Beichen Center for Disease Control and Prevention, Tianjin, China.
Yang HuangHebei University, Baoding, China.
Xi-Jie ZhengDepartment of Nephrology, Affiliated Hospital of Hebei University, Baoding, China.
Hang ChenDepartment of Nephrology, Affiliated Hospital of Hebei University, Baoding, China.
Zhun SuiDepartment of Nephrology, Peking University People's Hospital, Beijing, China.
Affiliated Hospital of Hebei University · CNHebei University · CNPeking University People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim of this study was to analyze the epidemiological characteristics of the causes of chronic kidney disease (CKD) stage 5 patients in North China and to investigate the economic burden of those on hemodialysis (HD) or peritoneal dialysis (PD), as well as the associated influencing factors. Methods: General clinical information, etiological categories, and hospitalization costs for HD or PD were collected from 1,515 patients hospitalized with stage 5 CKD at the Affiliated Hospital of Hebei University from 2016 to 2018. Logistic regression analysis was used to analyze the independent influencing factors affecting patients' financial burden. Results: The highest rate of DN was found in patients aged 70 years or older (27.0%) and the highest incidence of primary glomerulopathy was found in patients aged <50 years (24.3%). Age, type of dialysis, and type of health insurance were independent influences on the total financial burden of patients, and the results of multifactorial logistic regression analysis showed that age [OR (95% CI): 1.009 (1.002, 1.020)] and type of dialysis [OR (95% CI): 1.746 (1.149, 2.659)] would increase the total financial burden. The type of health insurance would reduce the total financial burden [OR (95% CI): 0.222 (0.108, 0.418)]. Conclusion: Chronic kidney disease, with its complex etiology and the heavy financial burden required for treatment, remains a more serious public health problem globally, and it is therefore necessary to further improve medical coverage for dialysis patients, increase management efforts, broaden pro-poor policies and increase the accessibility of medical services in low- and middle-income areas.

Indexed as

Kidney Failure, ChronicRenal Insufficiency, ChronicChinaHumansInpatientsRenal Dialysiseconomic burdenetiology analysishemodialysisperitoneal dialysisstage 5 CKD

Identifiers

PMID36530683
PMCPMC9751047
OpenAlexW4310535197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.